[go: up one dir, main page]

DE69332236D1 - Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay - Google Patents

Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay

Info

Publication number
DE69332236D1
DE69332236D1 DE69332236T DE69332236T DE69332236D1 DE 69332236 D1 DE69332236 D1 DE 69332236D1 DE 69332236 T DE69332236 T DE 69332236T DE 69332236 T DE69332236 T DE 69332236T DE 69332236 D1 DE69332236 D1 DE 69332236D1
Authority
DE
Germany
Prior art keywords
immunocomplex
dissociating
used therefor
reagent
immunoassay used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69332236T
Other languages
English (en)
Other versions
DE69332236T2 (de
Inventor
Jones Marvin Hyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25528576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69332236(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Application granted granted Critical
Publication of DE69332236D1 publication Critical patent/DE69332236D1/de
Publication of DE69332236T2 publication Critical patent/DE69332236T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Gyroscopes (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Selective Calling Equipment (AREA)
  • Seasonings (AREA)
DE69332236T 1992-11-25 1993-11-19 Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay Expired - Lifetime DE69332236T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/981,689 US5384240A (en) 1992-11-25 1992-11-25 Base dissociation assay

Publications (2)

Publication Number Publication Date
DE69332236D1 true DE69332236D1 (de) 2002-10-02
DE69332236T2 DE69332236T2 (de) 2003-04-17

Family

ID=25528576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69332236T Expired - Lifetime DE69332236T2 (de) 1992-11-25 1993-11-19 Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay

Country Status (13)

Country Link
US (1) US5384240A (de)
EP (1) EP0599417B1 (de)
JP (1) JP3398199B2 (de)
KR (1) KR100326619B1 (de)
AT (1) ATE223050T1 (de)
AU (1) AU674353B2 (de)
CA (1) CA2109855A1 (de)
DE (1) DE69332236T2 (de)
DK (1) DK0599417T3 (de)
ES (1) ES2182825T3 (de)
FI (1) FI935217L (de)
PT (1) PT599417E (de)
ZA (1) ZA938726B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484706A (en) * 1993-05-19 1996-01-16 Pasteur Sanofi Diagnostics Immunoassay for analytes in samples using alkylating agents
DE59712575D1 (de) * 1996-12-19 2006-04-20 Dade Behring Marburg Gmbh Immundissoziation zur Verbesserung der immunchemischen Bestimmung eines Analyten
EP0967484B1 (de) * 1997-08-04 2007-05-02 Advanced Life Science Institute, Inc. Methoden zum nachweis und zur analyse von virus
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
US20090118421A1 (en) * 2007-11-02 2009-05-07 Momentive Performance Materials Inc. Copolymer of epoxy compounds and amino silanes
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20100297610A1 (en) * 2009-04-15 2010-11-25 Columbia Biosystems Molecularly imprinted polymers for detecting hiv-1
ES2413437T3 (es) * 2010-03-10 2013-07-16 Institut Pasteur HMGB1 y anticuerpos anti-HMGB1 en pacientes infectados por VIH especialmente con trastornos neurológicos
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
JP5630866B2 (ja) * 2010-12-24 2014-11-26 栄研化学株式会社 Ｈｉｖの検出方法
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN104697830B (zh) * 2015-02-10 2018-06-15 深圳市新产业生物医学工程股份有限公司 用于hiv检测的酸性处理剂、样本预处理方法、试剂盒及检测方法
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
JP2019523863A (ja) * 2016-05-31 2019-08-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ウイルス抗原の血清学的検出方法
JP2021508836A (ja) * 2017-12-22 2021-03-11 スゲンテック, インク.Sugentech, Inc. 結核診断方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299812A (en) * 1978-11-29 1981-11-10 Diagnostic Products Corp. Immunoassay of thyroxine in neonates using dried blood samples
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
US4965191A (en) * 1988-02-12 1990-10-23 Eastman Kodak Company Lower alcohol sulfate wash solution, test kit and method for the determination of an immunological ligand
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
US5132205A (en) * 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
US5047325A (en) * 1988-10-07 1991-09-10 Eastman Kodak Company Wash solution containing a cationic surfactant and its use in chlamydial and gonococcal determinations
US5081010A (en) * 1989-02-09 1992-01-14 Eastman Kodak Company Extraction composition, test kit and their use to extract or determine herpes simplex viral antigen
US5124245A (en) * 1989-02-09 1992-06-23 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen
US5210039A (en) * 1989-02-09 1993-05-11 Eastman Kodak Company Wash composition, test kit and their use to determine a herpes simplex viral antigen

Also Published As

Publication number Publication date
CA2109855A1 (en) 1994-05-26
FI935217L (fi) 1994-05-26
KR940011950A (ko) 1994-06-22
ZA938726B (en) 1994-08-01
FI935217A0 (fi) 1993-11-24
EP0599417B1 (de) 2002-08-28
PT599417E (pt) 2002-12-31
DE69332236T2 (de) 2003-04-17
EP0599417A2 (de) 1994-06-01
AU674353B2 (en) 1996-12-19
AU5190793A (en) 1994-06-09
DK0599417T3 (da) 2003-01-06
US5384240A (en) 1995-01-24
EP0599417A3 (de) 1995-05-17
KR100326619B1 (ko) 2002-06-20
JPH06242112A (ja) 1994-09-02
ATE223050T1 (de) 2002-09-15
ES2182825T3 (es) 2003-03-16
JP3398199B2 (ja) 2003-04-21

Similar Documents

Publication Publication Date Title
DE69332236D1 (de) Verfahren zur Dissoziierung von einem Immunokomplex und dafür verwendeter Immunoassay
DE69324751D1 (de) Verfahren zur bestimmung von peptiden, die immunologisch wichtigen epitopen von hcv zugehörig sind
NO870412D0 (no) Peptider.
ATE15945T1 (de) Verfahren zum nachweis von haemoglobin in faezes.
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
ATE128738T1 (de) Verfahren zum schnellen und empfindlichen nachweis von igm-antikörpern gegen retrovirale antigene.
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
ATE228248T1 (de) Verfahren zur simultanen bestimmung von hiv- antigenen und hiv-antikörpern
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE185605T1 (de) Nachweis von hepatits c mit verwendung rekombinanter antigene
ATE145246T1 (de) Monoklonale antikörper zur induzierung von toleranz
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE132268T1 (de) Immuntest zum gleichzeitigen nachweis von hiv-1, hiv-2, htlv-i und htlv-ii antikörpern
ATE64783T1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
DE59309215D1 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes
EP0402757A3 (de) Festphasenimmunoassay und Testbesteck zur Bestimmung von Antigenen und Antikörpern
ATE138078T1 (de) Analysemethode für infektiöse pferdeanämie-viren (eia-virus)
ATE54758T1 (de) Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus.
GR890100219A (el) Ανθρωπινα μονοκλωνικα αντισωματα που ειδικα αναγνωριζουν κυτταραιου λυσσας κυτταρα που παραγουν τα ιδια, διαμορφωσεις που περιε χουν τα ιδια και παραγωγη ολων αυτων.
DE58902996D1 (de) Verfahren zum nachweis von antikoerpern gegen erythrozytenspezifische antigene.
DE3854665D1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.

Legal Events

Date Code Title Description
8363 Opposition against the patent